Search

A new report from MIT suggests that universities should avoid concentrating too much on technology transfer.

As expected, the IPO markets in Europe made their strongest showing in several years in 2005 and have even topped the amount of money raised in the U.S., according to figures released today by PricewaterhouseCoopers in London.

A new report on the state of micromanufacturing around the world.

Forget stem cells, pharmacogenomics and the next big cure - Michael Kenward gazes into his prophecy book to see what the physical sciences have in store for us this year. Or maybe not.

Scientists at Edinburgh University have developed a new method for cleaning surgical instruments that entirely removes protein contamination, including the near-indestructible prions - the agents that cause mad cow disease

The first investor-ready company has rolled off the production line in a scheme set up by the development agency Yorkshire Forward to commercialise research from the UK county's universities.

Just as most public research bodies embrace commercialisation as their raison d'etre, the UK Medical Research Council is reversing the trend and taking a company it span out earlier back within its fold.

Charges of scientific fraud in Korea aren't likely to faze Britain's ambitious stem-cell efforts, as evidenced by plans for a £40 million lab run by the 'father' of Dolly the sheep.

The countries of Scandinavia and the Baltic have got together to maximise the value of intellectual property, the feedstock of the knowledge economy.

Lab-supply companies are normally in the business of selling things to scientists, rather than buying. But the new CEO of Sigma-Aldrich, one of the world's largest lab-supply firms, is shopping for new ideas, new partners - and new companies to invest in.

"I didn't think they would be at this stage for decades, let alone within a year." Gerald Schatten, colleague of Korea's stem-cell celebrity, before scandal broke

European exchanges are opening back up for riskier ventures, and experts expect the trend to continue. But trade-sales should still dominate, says Mary Lisbeth D'Amico.

Sworn enemies within the technology and pharmaceutical industries are joining forces in a lobbying drive to persuade European Union lawmakers to change a draft law they say will stifle innovation in Europe by criminalising patent infringements, along with all forms of intellectual property infringements.

Time and money are driving the world’s pharmaceutical companies east for their clinical trials. With its huge population, new helpful regulations and growth outstripping China, India plans to become the world leader in the clinical research business by the end of the decade.